Unknown

Dataset Information

0

Biologic Therapy for the Treatment of Giant Cell Arteritis.

ABSTRACT: Giant cell arteritis (GCA), a vasculitis of the medium and large arteries, is traditionally managed with glucocorticoids. However, the side effects of chronic glucocorticoid use and the occurrence of refractory cases warrant the consideration of steroid-sparing agents, including biologic agents. Interleukin-6 (IL-6) inhibition shows the most promise as biologic therapy for refractory cases of GCA, but data to support the use of other existing biologic agents are currently lacking. A better understanding of the pathogenesis of GCA as well as clinical trials investigating both existing and emerging biologic agents is needed to expand therapeutic options for the treatment of GCA.

SUBMITTER: Ostrowski RA 

PROVIDER: S-EPMC5123077 | biostudies-other | 2014

REPOSITORIES: biostudies-other

Json Xml
altmetric image

Publications

Biologic Therapy for the Treatment of Giant Cell Arteritis.

Ostrowski Rochella A RA   Bussey Melissa R MR   Tehrani Rodney R   Jay Walter W  

Neuro-ophthalmology (Aeolus Press) 20140402 3

Giant cell arteritis (GCA), a vasculitis of the medium and large arteries, is traditionally managed with glucocorticoids. However, the side effects of chronic glucocorticoid use and the occurrence of refractory cases warrant the consideration of steroid-sparing agents, including biologic agents. Interleukin-6 (IL-6) inhibition shows the most promise as biologic therapy for refractory cases of GCA, but data to support the use of other existing biologic agents are currently lacking. A better under  ...[more]

Similar Datasets

Unknown Biologic Therapies for Giant Cell Arteritis.
| S-EPMC7797292 | biostudies-literature
Unknown Treatment failure in giant cell arteritis.
| S-EPMC8522464 | biostudies-literature
Unknown Treatment of Giant Cell Arteritis (GCA).
| S-EPMC8999932 | biostudies-literature
Unknown Endovascular Treatment of Intracerebral Giant Cell Arteritis.
| S-EPMC7177021 | biostudies-literature
Unknown Giant cell arteritis: Current treatment and management.
| S-EPMC4468893 | biostudies-other
Unknown Giant Cell Arteritis versus Takayasu Arteritis: An Update.
| S-EPMC7362112 | biostudies-literature
Unknown Tocilizumab for giant cell arteritis.
| S-EPMC9105486 | biostudies-literature
Unknown Tocilizumab for giant cell arteritis.
| S-EPMC8406620 | biostudies-literature
Unknown Need and value of targeted immunosuppressive therapy in giant cell arteritis.
| S-EPMC8845325 | biostudies-literature
Unknown Current developments in the diagnosis and treatment of giant cell arteritis.
| S-EPMC9792614 | biostudies-literature